Loading clinical trials...
Loading clinical trials...
Alzheimer's disease (AD) is the most common neurodegenerative disorder afflicting the elderly. Currently, some biochemical tests performed on Cerebrospinal Fluid (CSF) samples have demonstrated to dis...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT05655195 · Alzheimer Disease, Alzheimer Disease, Early Onset, and more
NCT03653156 · Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, and more
NCT06448403 · Mild Cognitive Impairment, Alzheimer Disease, Late Onset, and more
NCT06765434 · Alzheimer Disease, Late Onset, Cognitive Impairment
NCT04263194 · Alzheimer Disease, Late Onset, Alzheimer Disease, and more
UZ Leuven
Leuven
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions